Empagliflozin vs Montelukast

## Empagliflozin vs Montelukast: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Montelukast**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Montelukast**: Selective leukotriene D4 receptor antagonist.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Montelukast — 2.7-5.5 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Montelukast — C35H36ClNO3S.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Montelukast — 586.1800 g/mol.

**Type**: Empagliflozin — Small molecule; Montelukast — Small molecule.